Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated:  12/31/1969
Medical University
4608
mi
from 43215
Vienna,
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated: 12/31/1969
Medical University
4608
mi
from 43215
Vienna,
Click here to add this to my saved trials
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography (NORDICA Study)
Status: Enrolling
Updated:  12/31/1969
UNC Center for Heart & Vascular Care
353
mi
from 43215
Chapel Hill, NC
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography (NORDICA Study)
Status: Enrolling
Updated: 12/31/1969
UNC Center for Heart & Vascular Care
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Women's Care of Nashua
629
mi
from 43215
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Women's Care of Nashua
629
mi
from 43215
Nashua, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Dartmouth-Hitchcock Nashua
629
mi
from 43215
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Dartmouth-Hitchcock Nashua
629
mi
from 43215
Nashua, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Southern New Hampshire Medical Center
629
mi
from 43215
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Southern New Hampshire Medical Center
629
mi
from 43215
Nashua, NH
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
1955
mi
from 43215
Duarte, CA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
University of Minnesota, Masonic Cancer Center
624
mi
from 43215
Minneapolis, MN
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
University of Minnesota, Masonic Cancer Center
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
2
mi
from 43215
Columbus, OH
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital-Winship Cancer Institute
436
mi
from 43215
Atlanta, GA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Stanford University
2100
mi
from 43215
Palo Alto, CA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Wayne State University
165
mi
from 43215
Detroit, MI
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University
165
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
1335
mi
from 43215
Albuquerque, NM
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
1335
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
RTI International
360
mi
from 43215
Durham, NC
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
RTI International
360
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Duke University
352
mi
from 43215
Durham, NC
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
97
mi
from 43215
Cincinnati, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
3
mi
from 43215
Columbus, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
3
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
619
mi
from 43215
Providence, RI
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
990
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Evaluation of Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Evaluation of Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network - Randomized Control Trial
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania - Medical Intensive Care Unit
416
mi
from 43215
Philadelphia, PA
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network - Randomized Control Trial
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania - Medical Intensive Care Unit
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Status: Enrolling
Updated:  12/31/1969
Indiana University d/b/a/ Methodist Research Institute
167
mi
from 43215
Indianapolis, IN
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Status: Enrolling
Updated: 12/31/1969
Indiana University d/b/a/ Methodist Research Institute
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department
Status: Enrolling
Updated:  12/31/1969
Brooklyn Hospital Center
478
mi
from 43215
Brooklyn, NY
Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department
Status: Enrolling
Updated: 12/31/1969
Brooklyn Hospital Center
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated:  12/31/1969
New Mexico Heart Institute
1333
mi
from 43215
Albuquerque, NM
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated: 12/31/1969
New Mexico Heart Institute
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
VR High Tech Pain Control Burn Wound Care
High Technology Pain Control During Burn Wound Care
Status: Enrolling
Updated:  12/31/1969
University of Washington; Harborview Medical Center
2006
mi
from 43215
Seattle, WA
VR High Tech Pain Control Burn Wound Care
High Technology Pain Control During Burn Wound Care
Status: Enrolling
Updated: 12/31/1969
University of Washington; Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Peri-operative NIRS Monitoring In Infants
Cerebral Near-infrared Spectroscopy Monitoring in Infants During the Peri-operative Period: a Prospective Observational Cohort Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Peri-operative NIRS Monitoring In Infants
Cerebral Near-infrared Spectroscopy Monitoring in Infants During the Peri-operative Period: a Prospective Observational Cohort Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
AKDHC Medical Research Services, LLC
1662
mi
from 43215
Phoenix, AZ
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
AKDHC Medical Research Services, LLC
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
AKDHC Medical Research Services, LLc
1639
mi
from 43215
Tucson, AZ
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
AKDHC Medical Research Services, LLc
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
VA Loma Linda Healthcare System
1919
mi
from 43215
Loma Linda, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
VA Loma Linda Healthcare System
1919
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Long Beach
1972
mi
from 43215
Long Beach, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Long Beach
1972
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
1944
mi
from 43215
San Diego, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
1944
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
California Institute of Renal Research
1947
mi
from 43215
San Diego, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
California Institute of Renal Research
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Northern California
2108
mi
from 43215
San Francisco, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Northern California
2108
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Chicago
270
mi
from 43215
Chicago, IL
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital Network of Indiana
136
mi
from 43215
Fort Wayne, IN
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital Network of Indiana
136
mi
from 43215
Fort Wayne, IN
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials